Medtronic on Nov. 21 posted its financial results for the second quarter of the fiscal year 2024.
Four things to know:
1. The company saw a 5.3% revenue increase year-over-year with $8 billion.
2. Medtronic's neuroscience portfolio saw a 4.7% year-over-year increase with $2.28 billion.
3. The cranial and spinal technologies segment saw a 7% increase year-over-year with $1.2 billion.
4. Medtronic raised its revenue growth guidance to 4.75%.